LOMITAPIDE, 95%, 250mg

2-Vinylthiophene, 97.0%, 10g

dibutyl[(oxiran-2-yl)methyl]amine, 95.0%, 2g

Oxyde d'hydroxyde de fer(III), minimum 85 % Fe2O3, technique, 250 g, emballage plastique.

4-(4-chloro-3-nitrobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 2g

5-Methylcytosine, 95.0%, 500g

Hexamethylbenzene, 98.0%, 100g

Ethyl isoxazole-4-carboxylate, 95.0%, 100mg

2-Picoline-5-boronic acid hydrate, 95.0%, 1g

Adamantan-1-ylmethyl-methyl-amine, 95.0%, 2.5g

2,6-Diaminoanthracene-9,10-dione, 95.0%, 25g

Ethyl 3-Fluoro-4-nitrobenzoate, 97.0%, 10g

1-(5-Chloro-4-nitro-1H-pyrazol-1-yl)-2-methylpropan-2-ol, 95.0%, 250mg